Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer have?
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer has 385 citations in the OpenAlex counts ScholarIQ stores.
When was Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer published?
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer?
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer has closed oa status in the ScholarIQ index.
What is the DOI of Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer?
The DOI for Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer is on the source record.
What is the PMID of Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer?
The PMID for Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer is on the source record.
What is the OpenAlex record for Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer?
The OpenAlex for Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer is on the source record.